The US FDA has approved a new treatment for schizophrenia that promises fewer side effects than existing options. This marks a significant step forward in mental health medication.
Treatment Features
The drug targets symptoms with reduced risk of weight gain and other common issues. Clinical trials showed improved patient outcomes.
Impact on Healthcare
It could benefit millions suffering from schizophrenia, with availability expected soon.